WINT
Income statement / Annual
Last year (2023), Windtree Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Windtree Therapeutics, Inc.'s net income was -$20.29 M.
See Windtree Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$198,000.00
|
$1.79 M
|
$1.49 M
|
$2.04 M
|
$987,000.00
|
$2.84 M
|
Cost of Revenue |
$82,000.00 |
$1.06 M |
$869,000.00 |
$638,000.00 |
$12,687.00 |
$10.56 M |
$17.38 M |
$255,000.00 |
$929,000.00 |
$2.67 M |
Gross Profit |
-$82,000.00 |
-$1.06 M |
-$869,000.00 |
-$638,000.00 |
$185,313.00 |
-$8.77 M |
-$15.89 M |
$1.79 M |
$58,000.00 |
$164,000.00 |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0.94 |
-4.91 |
-10.7 |
0.88 |
0.06 |
0.06 |
Research and Development
Expenses |
$8.34 M
|
$11.10 M
|
$17.79 M
|
$15.37 M
|
$12.69 M
|
$10.56 M
|
$17.38 M
|
$31.71 M
|
$28.89 M
|
$26.69 M
|
General & Administrative
Expenses |
$8,698.00
|
$10.79 M
|
$14.47 M
|
$14.94 M
|
$12.40 M
|
$7.42 M
|
$6.66 M
|
$7.17 M
|
$0.00
|
$0.00
|
Selling & Marketing
Expenses |
$9.19 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.20 M
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$9.20 M
|
$10.79 M
|
$14.47 M
|
$14.94 M
|
$12.40 M
|
$7.42 M
|
$6.66 M
|
$8.37 M
|
$11.00 M
|
$16.73 M
|
Other Expenses |
$0.00 |
$702,000.00 |
-$320,000.00 |
-$2.25 M |
-$446,000.00 |
$401,000.00 |
$129,000.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$17.46 M |
$21.89 M |
$32.26 M |
$30.32 M |
$25.09 M |
$17.98 M |
$24.03 M |
$40.08 M |
$39.89 M |
$43.42 M |
Cost And Expenses |
$17.54 M |
$21.89 M |
$32.26 M |
$30.32 M |
$25.09 M |
$17.98 M |
$24.03 M |
$40.08 M |
$40.82 M |
$46.09 M |
Interest Income |
$325,000.00 |
$109,000.00 |
$91,000.00 |
$122,000.00 |
$153,000.00 |
$15,000.00 |
$12,000.00 |
$18,000.00 |
$237,000.00 |
$6,000.00 |
Interest Expense |
$50,000.00 |
$53,000.00 |
$114,000.00 |
$125,000.00 |
$495,000.00 |
$1.41 M |
$1.86 M |
$2.52 M |
$4.67 M |
$4.60 M |
Depreciation &
Amortization |
$82,000.00
|
$1.06 M
|
$869,000.00
|
$638,000.00
|
$1.11 M
|
$159,000.00
|
$192,000.00
|
$255,000.00
|
$712,000.00
|
$818,000.00
|
EBITDA |
-$20.16 M
|
-$39.46 M
|
-$76.64 M
|
-$31.80 M
|
-$25.87 M
|
-$18.97 M
|
-$16.39 M
|
-$36.72 M
|
-$49.88 M
|
-$38.64 M
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
-116.66 |
-8.74 |
-14.96 |
-19.14 |
-39.4 |
-14.98 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
-125.72
|
-9.06
|
-15.18
|
-18.63
|
-40.36
|
-15.26
|
Total Other
Income/Expenses Net |
-$2.75 M
|
-$19.09 M
|
-$45.36 M
|
-$2.25 M
|
-$2.58 M
|
-$4.34 M
|
$4.10 M
|
-$1.45 M
|
-$15.34 M
|
-$800,000.00
|
Income Before Tax |
-$20.29 M |
-$40.58 M |
-$77.62 M |
-$32.57 M |
-$27.48 M |
-$20.53 M |
-$18.45 M |
-$39.49 M |
-$55.17 M |
-$44.06 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
-138.76
|
-11.48
|
-12.42
|
-19.34
|
-55.9
|
-15.54
|
Income Tax Expense |
$0.00 |
-$1.37 M |
-$9.99 M |
-$2.29 M |
$2.39 M |
-$2.93 M |
$1.99 M |
$1.20 M |
$4.67 M |
-$18,000.00 |
Net Income |
-$20.29 M |
-$39.21 M |
-$67.64 M |
-$30.28 M |
-$29.86 M |
-$20.53 M |
-$18.45 M |
-$39.49 M |
-$55.17 M |
-$44.06 M |
Net Income Ratio |
0 |
0 |
0 |
0 |
-150.82 |
-11.48 |
-12.42 |
-19.34 |
-55.9 |
-15.54 |
EPS |
-92.23 |
-980.2 |
-2254.53 |
-1514 |
-2986.2 |
-685.51 |
-2691.67 |
-14230.63 |
-23759.69 |
-21746.3 |
EPS Diluted |
-92.23 |
-980.2 |
-2254.53 |
-1514 |
-2986.2 |
-685.51 |
-2691.67 |
-14230.63 |
-23759.69 |
-21512.7 |
Weighted Average Shares
Out |
$220,000.00
|
$40,000.00
|
$30,000.00
|
$20,000.00
|
$10,000.00
|
$29,953.00
|
$6,853.00
|
$2,775.00
|
$2,322.00
|
$2,026.00
|
Weighted Average Shares
Out Diluted |
$220,000.00
|
$40,000.00
|
$30,000.00
|
$20,000.00
|
$10,000.00
|
$29,953.00
|
$6,853.00
|
$2,775.00
|
$2,322.00
|
$2,048.00
|
Link |
|
|
|
|
|
|
|
|
|
|